Webb29 nov. 2024 · Item 8.01. Other Events. On November 29, 2024, 9 Meters Biopharma, Inc. issued a press release announcing the design of its Phase 3 clinical trial of vurolenatide for adults with short bowel... February 21, 2024 Webb18 okt. 2024 · 9 Meters Biopharma, Inc. is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, GI conditions with unmet needs, and debilitating disorders in which the biology of the gut is a contributing factor. 9 Meters is developing vurolenatide, a proprietary long-acting GLP-1 agonist and several near …
9 Meters Biopharma Provides Business Update and Reports …
Webb9 Meters initiated the VIBRANT study (VurolenatIde for short Bowel syndrome Regardless of pArenteral support requiremeNT), a placebo-controlled Phase 2 trial in SBS in Q2 … Webb19 okt. 2024 · RALEIGH, NC / ACCESSWIRE / October 19, 2024 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people … blanx toothpaste glossy white
9 METERS BIOPHARMA, INC. : Other Events, Financial Statements …
Webb9 feb. 2024 · About 9 Meters Biopharma 9 Meters Biopharma is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, GI conditions with unmet needs, and debilitating disorders in which the biology of … Webb19 okt. 2024 · RALEIGH, NC / ACCESSWIRE / October 19, 2024 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, announced today that the company will deliver a poster presentation highlighting vurolenatide, 9 Meters' … Webb15 nov. 2024 · RALEIGH, NC / ACCESSWIRE / November 15, 2024 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, today provided a business update and reported financial results for the third … blanx whitening strips